Cargando…
DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy
Cardiac hypertrophy (CH) is an independent risk factor for cardiovascular diseases (CVDs). Mitigating or preventing CH is the most effective strategy for the treatment of CVDs. DanHong injection (DH) is a Chinese herbal medicine preparation (CHMP) widely used in clinical treatment of several CVDs in...
Autores principales: | Zhang, Min-Yu, Guo, Fei-Fei, Wu, Hong-Wei, Yu, Yang-Yang, Wei, Jun-Ying, Wang, Shi-Feng, Zhang, Yu-Xin, Xian, Ming-Hua, Wu, Qing-Hua, Zhao, Bu-Chang, Li, Shi-You, Yang, Hong-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732736/ https://www.ncbi.nlm.nih.gov/pubmed/29262570 http://dx.doi.org/10.18632/oncotarget.21900 |
Ejemplares similares
-
Alteration of Amino Acid Profiling Influenced by the Active Ingredients of DanHong Injection After Prescription Optimization
por: Guo, Zhili, et al.
Publicado: (2019) -
Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directed-degeneration method
por: Han, Seong-Gu, et al.
Publicado: (2017) -
Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma
por: Wei, Feiran, et al.
Publicado: (2020) -
The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
por: Zou, Jun-Bo, et al.
Publicado: (2018) -
Endothelin-1/Endothelin Receptor Type A-Angiopoietins/Tie-2 Pathway in Regulating the Cross Talk Between Glomerular Endothelial Cells and Podocytes in Trichloroethylene-Induced Renal Immune Injury
por: Xie, Haibo, et al.
Publicado: (2021)